Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/10256/10901
dc.contributor.author | Blancafort, Adriana |
---|---|
dc.contributor.author | Giró Perafita, Ariadna |
dc.contributor.author | Oliveras, Glòria |
dc.contributor.author | Palomeras, Sònia |
dc.contributor.author | Turrado, Carlos |
dc.contributor.author | Campuzano Larrea, Oscar |
dc.contributor.author | Carrion Salip, Dolors |
dc.contributor.author | Massaguer i Vall-llovera, Anna |
dc.contributor.author | Brugada, Ramon |
dc.contributor.author | Palafox, Marta |
dc.contributor.author | Gómez Miragaya, Jorge |
dc.contributor.author | González Suárez, Eva |
dc.contributor.author | Puig Miquel, Teresa |
dc.date | 2015-09-14T06:48:51Z |
dc.date | 2015-09-14T06:48:51Z |
dc.date | 2015 |
dc.identifier.citation | 1932-6203 |
dc.identifier.citation | 023565 |
dc.identifier.uri | http://hdl.handle.net/10256/10901 |
dc.format | 22 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Public Library of Science (PLoS) |
dc.relation | http://dx.doi.org/10.1371/journal.pone.0131241 |
dc.relation | Reproducció digital del document publicat a: http://dx.doi.org/10.1371/journal.pone.0131241 |
dc.relation | PLoS One, 2015, vol. 10, núm. 6, p. e0131241 |
dc.relation | Articles publicats (D-CM) |
dc.rights | Reconeixement 3.0 Espanya |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es |
dc.source | Blancafort, Adriana Giró-Perafita, Ariadna Oliveras, Glòria Palomeras, Sònia Turrado, Carlos Campuzano Larrea, Oscar Carrion-Salip, Dolors Massaguer i Vall-llovera, Anna Brugada, Ramon Palafox, Marta Gómez-Miragaya, Jorge González-Suárez, Eva Puig Miquel, Teresa 2015 Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs PLoS One 10 6 e0131241 |
dc.subject | Mama -- Càncer |
dc.subject | Breast -- Cancer |
dc.title | Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |